Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting

Completed · Phase 4

Conditions studied: Influenza

In brief

The purpose of the study is to compare the performance of two currently available influenza (flu) vaccines. This study will try and determine if the high dose flu vaccine provides protection that is the same or better than that of regular dose flu vaccine. Both the regular dose and the high dose flu vaccines are approved by the FDA for use in older adults.

Key facts

Study ID

NCT01654224

Run by

University of Pittsburgh

People needed

205

Starts

2011-11-01

Expected to finish

2014-06-01

Last updated by the study team

2017-07-02

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Residents of one of the participating LTC sites
• 65 years or older at the time of consent
• require assistance in two or more Instrumental Activities of Daily Living and/or one or more Activities of Daily Living as identified by facility staff

You may not qualify if…

• Age less than 65 years
• Life expectancy less than 6 months
• History of allergic reaction to influenza vaccine, its components, or eggs
• History of severe allergic reaction to latex
• History of Guillian-Barre Syndrome
• Actively undergoing chemotherapy
• Actively undergoing radiation therapy
• Use of prednisone (or other steroid) at prednisone-equivalent dosages of 10mg or higher within the past 14 days
• Serious current immunosuppression or immunosuppression expected in the next 6 weeks
• Any condition that, in the opinion of the investigator,might interfere with the evaluation of study objectives

Where it is running

• University of Pittsburgh, Division of Geriatric Medicine — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.